Report: Vitamin C Cancer Study Flawed

A study from Cancer Research said high doses of vitamin C caused chemotherapy drugs to be ineffective in cancer patients; however, a report in Alternative and Complementary Therapies said the study was flawed because the researcher used an oxidized form of vitamin C known as dehydroascorbic acid, which is not used as a as a dietary supplement in humans and because the mice in the study were give toxic doses of the acid. Nutrition expert Jack Challem wrote the report and said high doses of vitamin C are beneficial to human cancer patients and should be tailored along with other treatments for individuals. Vitamin C is believed to encourage the death of tumor cells, assist in post surgical healing and increase the resistance of tissues to metastases.